Header Logo

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet. 2018 Feb; 4(1):e216.

View in: PubMed